Objective We aimed to explore the clinical efficacy of LEEP operation combined with Qilin TCM decoction on decreasing of postoperative complications, improve TCM syndrome, promoting HPV clearance and cervical intraepithelial lesions (CIN) recovery. Methods A total of 400 cases with CIN I-II after LEEP operation, according with TCM diagnostic standards of morbid leukorrhea disease (dampness heat with blood toxin stasis type) were randomly divided into 4 groups (Qilin TCM decoction groups, Baofukang suppository group, Qilin TCM decoction combined with Baofukang suppository group, blank control group, 100 cases in each group). All participants were given corresponding adjuvant therapy for three courses,regularly followed up at 2、1、3、6 and 12 months after operation, Postoperative complications、improvement of TCM syndromes, cervical HPV clearance、cytology (TCT) recovery and prognosis of cervical precancerous lesions(CIN)were compared among the fours groups. Results A total of 360 cases were collected. Among them, there were 95 cases in Qilin TCM decoction group, 94 cases in Baofukang suppository group, 92 cases in Qilin TCM decoction combined with Baofukang suppository group, 79 cases in blank control group. The incidence of cervical infection and bleeding complications in combined medication group (4.4%、6.5%)and Qilin TCM decoction Group (6.3%、7.4%) was significantly lower than that in Baofukang suppository group (7.5%, 10.6%) and blank control group (11.4%, 12.7%), but there was no significant difference between the combined medication group and the Qilin TCM decoction Group(4.4%/6.3%、6.5%/7.4%,P>0.05); The improvement rate of TCM syndrome in combined medication group and Qilin TCM decoction Group was significantly higher than that in Baofukang suppository group and blank control group, respectively (P <0.05), but there was no significant difference between combined medication group and Qilin TCM decoction Group (P>0.05). HPV clearance rate, recovery rate of TCT, total effective treatmentrate of CIN in combined medication group (91.3%, 90.2%, 93.5%) were significantly higher than those in Qilin TCM decoction Group (85.3%, 82.1%, 85.3%), Baofukang suppository group (73.4%, 69.2%, 75.5%) and blank control group (67.1%, 63.3%, 70.1%), respectively. Conclusion LEEP operation combined with Qilin TCM Decoction and Bafukang suppository to treat CIN I-II patients is more effective in anti-tumor, anti-virus, anti-inflammatory and enhancing immunity, and effectively decreases postoperative complications, improves leucorrhea and whole body TCM Syndrome, scavenge HPV virus, expedites the recovery of cervical cytology (TCT), promotes the transformation of cervical atypical hyperplasia to normal tissue,it is worthy of clinical application.
Key words
cervical intraepithelial neoplasia /
HPV infection /
leukorrheal diseases /
LEEP /
traditional Chinese medicine (TCM)
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 郎景和.子宫颈癌预防的现代策略.中国医学科学院学报,2007,29:575-578.
2 张宁,刘笑梅.宫颈人乳头瘤病毒持续性感染的临床研究进展.国际生物医学工程杂志,2018,41:348-353.
3 Correnti M,Medina F,Cavazza ME,et al.Human papilloma virus (HPV) type distribution in cervical carcinoma,low-grade,and high-grade squamous intraepithelial lesions in Venezuelan women.Gynecol Oncol,2011,121:527-531.
4 于妍妍,金哲,黄文玲,等.中西医结合防治人乳头瘤病毒感染研究进展.北京中医药学,2012,31:555-560.
5 谢辛,苟文丽.妇产科学.第8版.北京:人民卫生出版社,2013:256-260.
6 张玉珍.中医妇科学.新2版.北京:中国中医药出版社,2014:95-108.
7 吕佩瑾,鲁永鲜.妇科疾病诊断与疗效标准.上海:上海中医药大学出版社,2006:268-271.
8 郑筱萸.中药新药临床研究指导原则.北京:中国医药科技出版社,2002:371-375.
9 陈春林.中国宫颈癌临床诊疗与大数据.中国实用妇科与产科杂志,2018,34:25-29.
10 Ulrich D,Tamussino K,Petru E,et al.Conization of the Uterine Cervix:Does the Level of Gynecologist’s Training Predict Margin Status? Int J Gynecol Pathol,2012,31:382-386.
11 张蓉,张书燕,宋芳霞.LEEP治疗CIN后高危型HPV的变化及临床意义.吉林医学,2014,35:7398-7399.
12 宝璋.中医妇科学.第五版.上海:上海科学技术出版社,2002:111-116.
13 李娟,蔡勤华.中医药治疗宫颈人乳头瘤病毒感染的研究现状.光明中医,2014,30:368-369.
14 张蔚苓,胡国华,叶利群.中西医治疗宫颈人乳头瘤病毒感染研究概况.山东中医药大学学报,2014,38:190-192.
15 张鹏,赵启韬,杨培民.白花蛇草核苷体外抗肿瘤作用实验研究.时珍国医国药,2012,23:1901-1902.
16 石云,贺珊,赵健.保妇康栓促进宫颈环形电切除术后创面愈合疗效观察.中国实用妇科与产科杂志,2015,31:55-60.
17 张春梅.黄芪的现代药理研究及其临床应用.医学信息,2016,29:291-292.
18 邵芳芳.保妇康栓联合宫颈环形电切术治疗宫颈上皮内瘤变伴高危型人乳头瘤病毒感染疗效观察.新中医,2016,31:145-148.
19 张小燕,卞美璐,房青,等.保妇康栓对人乳头状瘤病毒抑制作用的实验研究.中日友好医院学报,2007,2l:216-219.
20 高文芹,贾力,赵余庆.人参的抗癌作用及其机制研究进展.药物评价研究,2011,34:53-59.
21 王珺.加味完带汤联合中药外用干预宫颈上皮内瘤变术后临床观察.广西中医药,2013,36:31-32.
22 贾琳钰,王辉,王惠国,等.中医药治疗宫颈HPV 感染研究进展.中医药信息,2018,35:110-113.
{{custom_fnGroup.title_en}}
Footnotes
{{custom_fn.content}}